Balsalazide Disodium Capsule
Product Images NDC 50268-102

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Balsalazide Disodium (NDC 50268-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

FDA Label Image

Label 5026810313 Balsalazide 2017

This is a description of Balsalazide Disodium Capsules, USP, with NDC 50268-102-13. It comes in a unit dose pack of 30 capsules. Each capsule contains 750mg of balsalazide disodium. The usual dosage instructions can be found in the package insert. It is a prescription drug and should be stored at 20° to 25°C (68° to 77°F), with excursions allowed to 15-30°C (59° to 86°F). It is manufactured by AVKARE, Inc. and should be kept out of reach of children.*

FDA Label Image

Structural-formula (Structural Formula)

Not available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.